Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

II.b

ARDS - Acute lung injury

Publications

Lee Y, Chung TY, Liu HC

A rare case of acute respiratory distress syndrome caused by use of gadolinium-based magnetic resonance imaging contrast media.

Respirology case reports. 2019;7(8):e00483

Kerget B, Aksakal A, Afşin DE, Araz O, Ucar EY, Akgün M, Sağlam L

Acute respiratory distress syndrome after the use of gadolinium contrast agent.

Respiratory medicine case reports. 2018;25:336-338

Park J, Byun IH, Park KH, Lee JH, Nam EJ, Park JW

Acute Respiratory Distress Syndrome after the Use of Gadolinium Contrast Media.

Yonsei medical journal. 2015;56(4):1155-7